Seragon Pharmaceuticals Report issue

For profit Phase 1
Founded: San Diego CA United States (2013)
Status: Acquired by Roche (2014)

Organization Overview

First Clinical Trial
2015
NCT02316509
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 1 Trials (1)

gdc-0927 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1